PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33468723-4	2021	Moreover, the expression of miR-141 in MDA-MB-436 cells treated with the PARP-1 inhibitor together with gemcitabine increased more than 10 times; additionally, the expression of miR-205 increased more in the context of combination therapy versus single exposure to olaparib.	gemcitabine	104-115	microRNA 205	Homo sapiens	178-185	
28719220-2	2017	We previously demonstrated that the combination of GEM and miR-205 provides an effective therapeutic strategy to sensitize GEM-resistant pancreatic cancer cells.	gemcitabine	123-126	microRNA 205	Homo sapiens	59-66	
24147037-0	2013	miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.	gemcitabine	57-68	microRNA 205	Homo sapiens	9-16	
23073476-3	2013	Gemcitabine resistant MIA PaCa-2 cells possessed distinct ALDH-positive CSC fraction expressing stem cell markers OCT3/4 and CD44 and chemoresistance marker class IIIbeta-tubulin (TUBB3) which decreases on transfection with miR-205 resulting in the restoration of chemosensitivity to gemcitabine.	gemcitabine	0-11	microRNA 205	Homo sapiens	224-231	
32869841-11	2020	Additionally, the overexpression of miR-205-5p attenuated drug resistance to gemcitabine but promoted the gemcitabine-induced cell apoptosis by inhibiting the PRKCE in-vivo.	gemcitabine	77-88	microRNA 205	Homo sapiens	36-43	
32869841-11	2020	Additionally, the overexpression of miR-205-5p attenuated drug resistance to gemcitabine but promoted the gemcitabine-induced cell apoptosis by inhibiting the PRKCE in-vivo.	gemcitabine	106-117	microRNA 205	Homo sapiens	36-43	
31602229-0	2019	miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.	gemcitabine	36-47	microRNA 205	Homo sapiens	0-7	
31602229-8	2019	Overexpression of miR-205-5p significantly augmented cytotoxicity effects of gemcitabine treatment in MDA-MB-231 and BT549 cells.	gemcitabine	77-88	microRNA 205	Homo sapiens	18-25	
31602229-11	2019	Additionally, following the established gemcitabine-resistant MDA-MB-231 cells (MDA-MB-231/GEM), ERp29 and HSP27 expression was upregulated and miR-205-5p was downregulated compared with parental cells.	gemcitabine	40-51	microRNA 205	Homo sapiens	144-151	
31602229-12	2019	Overexpression of miR-205-5p reversed gemcitabine resistance in MDA-MB-231/GEM cells.	gemcitabine	38-49	microRNA 205	Homo sapiens	18-25	
31602229-13	2019	In conclusion, the present study indicated that miR-205-5p may inhibit gemcitabine resistance in breast cancer cells via inhibition of ERp29 expression.	gemcitabine	71-82	microRNA 205	Homo sapiens	48-55